Chinook Therapeutics, Inc.
KDNY
NASDAQ Global Select40.39
USD
+0.09
- -
Total Valuation
Chinook Therapeutics, Inc. carries a market capitalization of 2.71B, placing it among publicly traded companies globally.
| Market Cap | 2.71B |
| Enterprise Value | N/A |
Stock Price Statistics
Chinook Therapeutics, Inc.'s stock has gained approximately 76.76149% over the past 52 weeks. The 50-day moving average sits at 36.70, while the 200-day moving average is 26.37.
| Beta (5Y) | N/A |
| 52-Week Price Change | 76.76149% |
| 50-Day Moving Average | 36.70 |
| 200-Day Moving Average | 26.37 |
| Average Volume (20 Days) | N/A |
Stock Splits
Chinook Therapeutics, Inc.'s most recent stock split took place on October 2, 2020 with a 5:1 split ratio.
| Last Split Date | 10/2/2020 |
| Split Ratio | 5:1 |